BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2
556 results:

  • 1. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
    Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
    [No Abstract]    [Full Text] [Related]  

  • 2. Myotubularin-related-protein-7 inhibits mutant (G12V) K-RAS by direct interaction.
    Weidner P; Saar D; Söhn M; Schroeder T; Yu Y; Zöllner FG; Ponelies N; Zhou X; Zwicky A; Rohrbacher FN; Pattabiraman VR; Tanriver M; Bauer A; Ahmed H; Ametamey SM; Riffel P; Seger R; Bode JW; Wade RC; Ebert MPA; Kragelund BB; Burgermeister E
    Cancer Lett; 2024 Apr; 588():216783. PubMed ID: 38462034
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparative analysis of kras4a and kras4b splice variants reveals distinctive structural and functional properties.
    Whitley MJ; Tran TH; Rigby M; Yi M; Dharmaiah S; Waybright TJ; Ramakrishnan N; Perkins S; Taylor T; Messing S; Esposito D; Nissley DV; McCormick F; Stephen AG; Turbyville T; Cornilescu G; Simanshu DK
    Sci Adv; 2024 Feb; 10(7):eadj4137. PubMed ID: 38354232
    [No Abstract]    [Full Text] [Related]  

  • 4. Fusion of old and new: Employing touch imprint slides for next generation sequencing in solid tumors.
    Aydin Mericoz C; Eren OC; Kulac I; Firat P
    Diagn Cytopathol; 2024 May; 52(5):264-270. PubMed ID: 38339821
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CDKN2A-p16 Deletion and Activated kras
    Sun J; Sepulveda JL; Komissarova EV; Hills C; Seckar TD; LeFevre NM; Simonyan H; Young C; Su G; Del Portillo A; Wang TC; Sepulveda AR
    Cell Mol Gastroenterol Hepatol; 2024; 17(5):769-784. PubMed ID: 38296052
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Oncogenic Fatty Acid Metabolism Rewires Energy Supply Chain in gastric Carcinogenesis.
    Won Y; Jang B; Lee SH; Reyzer ML; Presentation KS; Kim H; Caldwell B; Zhang C; Lee HS; Lee C; Trinh VQ; Tan MCB; Kim K; Caprioli RM; Choi E
    Gastroenterology; 2024 May; 166(5):772-786.e14. PubMed ID: 38272100
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Biological and targeting differences between the rare kras A146T and canonical kras mutants in gastric cancer models.
    Puliga E; De Bellis C; Vietti Michelina S; Capeloa T; Migliore C; Orrù C; Baiocchi GL; De Manzoni G; Pietrantonio F; Reddavid R; Fumagalli Romario U; Ambrogio C; Corso S; Giordano S
    Gastric Cancer; 2024 May; 27(3):473-483. PubMed ID: 38261067
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A comparison analysis of the somatic mutations in early-onset gastric cancer and traditional gastric cancer.
    Han X; Jia X; Sheng C; Li M; Han J; Duan F; Wang K
    Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102287. PubMed ID: 38253255
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Global burden, risk factors, clinicopathological characteristics, molecular biomarkers and outcomes of microsatellite instability-high gastric cancer.
    Zhang Z; Huang J; Li Y; Yan H; Xie J; Wang J; Zhao B
    Aging (Albany NY); 2024 Jan; 16(1):948-963. PubMed ID: 38224334
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Dynamic tuft cell expansion during gastric metaplasia and dysplasia.
    Jang B; Kim H; Lee SH; Won Y; Kaji I; Coffey RJ; Choi E; Goldenring JR
    J Pathol Clin Res; 2024 Jan; 10(1):e352. PubMed ID: 38117182
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. RHOA
    Schaefer A; Hodge RG; Zhang H; Hobbs GA; Dilly J; Huynh MV; Goodwin CM; Zhang F; Diehl JN; Pierobon M; Baldelli E; Javaid S; Guthrie K; Rashid NU; Petricoin EF; Cox AD; Hahn WC; Aguirre AJ; Bass AJ; Der CJ
    Sci Signal; 2023 Dec; 16(816):eadg5289. PubMed ID: 38113333
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD-L1 expression.
    Jing X; Luo Z; Wu J; Ye F; Li J; Song Z; Zhang Y; Shi M; Sun H; Fang Y; Jiang Y; Ji X
    Cancer Med; 2023 Dec; 12(24):21905-21919. PubMed ID: 38050871
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Characteristic Mutational Damages in gastric and Colorectal Adenocarcinomas.
    Yermekova S; Orazgaliyeva M; Goncharova T; Rakhimbekova F; Kaidarova D; Shatkovskaya O
    Asian Pac J Cancer Prev; 2023 Nov; 24(11):3939-3947. PubMed ID: 38019254
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genetic landscape and PD-L1 expression in Epstein-Barr virus-associated gastric cancer according to the histological pattern.
    Park JH; Cho HJ; Seo J; Park KB; Kwon YH; Bae HI; Seo AN; Kim M
    Sci Rep; 2023 Nov; 13(1):19487. PubMed ID: 37945587
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
    Karimpour M; Totonchi M; Behmanesh M; Montazeri H
    Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The ASH1L-AS1-ASH1L axis controls NME1-mediated activation of the RAS signaling in gastric cancer.
    Xie M; Zhang L; Han L; Huang L; Huang Y; Yang M; Zhang N
    Oncogene; 2023 Nov; 42(46):3435-3445. PubMed ID: 37805663
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Targeting Stem Cells and Dysplastic Features With Dual MEK/ERK and STAT3 Suppression in gastric Carcinogenesis.
    Kim H; Jang B; Zhang C; Caldwell B; Park DJ; Kong SH; Lee HJ; Yang HK; Goldenring JR; Choi E
    Gastroenterology; 2024 Jan; 166(1):117-131. PubMed ID: 37802423
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Bacterial lipopolysaccharide related genes signature as potential biomarker for prognosis and immune treatment in gastric cancer.
    Yuan T; Zhang S; He S; Ma Y; Chen J; Gu J
    Sci Rep; 2023 Sep; 13(1):15916. PubMed ID: 37741901
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. DNMT1 expression partially dictates 5-Azacytidine sensitivity and correlates with RAS/MEK/ERK activity in gastric cancer cells.
    Chen Z; Zhang L; Yang Y; Liu H; Kang X; Nie Y; Fan D
    Epigenetics; 2023 Dec; 18(1):2254976. PubMed ID: 37691391
    [TBL] [Abstract] [Full Text] [Related]  

  • 20.
    Mulkidjan RS; Saitova ES; Preobrazhenskaya EV; Asadulaeva KA; Bubnov MG; Otradnova EA; Terina DM; Shulga SS; Martynenko DE; Semina MV; Belogubova EV; Tiurin VI; Amankwah PS; Martianov AS; Imyanitov EN
    Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686416
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 28.